Thursday, February 23, 2017 4:04:25 PM
Agreed. I think that could be why your PhD physicist friend with all his training "knew" the new theory was wrong, and why some are certain that NNVC is a fraud that will eventually go bankrupt:
Failure to look at and accept evidence, due to preconceptions. It could be why there is no rebuttal of the science that has been presented for BLP and NNVC, except for repeated strong statements of "it can't be true!" and "it must be fraud!"
For instance, there is a claim "modern QM must be right, and anyone who says otherwise must be wrong." When presented with evidence that modern QM is wrong - for instance that the "quantum limit" for temperature has been broken, against all "laws of physics," this is ignored. Similarly, when presented with evidence that nanoviricides work well in animals, this evidence is belittled in every way possible, most commonly as "it's a conspiracy of fraud of all involved."
Some times these things just take a while to play out, when the evidence accumulates and can no longer be ignored.
So yeah, I am probably wasting my time if my goal is to convince those with strong preconceptions, if they don't have an open mind. That doesn't mean I will stop presenting the truth as I see it, nor stop considering all the evidence and possibilities to arrive at the truth.
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
- NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City • GlobeNewswire Inc. • 05/04/2023 10:45:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM